Resignation of CEO & Managing Director

Resignation of CEO & Managing Director

The Company CEO and Managing Director, Elmo De Alwis has today tendered his resignation to the Company as Chief Executive Officer and Managing Director, which the Board has accepted.


Mr De Alwis has agreed to continue in the role until the Board has identified and appointed his replacement. That process is under way.

Chairman John Stocker said "on behalf of the Board, I sincerely thank Elmo for his hard work and dedication throughout his 33 years with the business. Over this period, he has made a substantial contribution to the organisation. "The Company will advise further on the outcome of its search as soon as it is completed.
Sue Morgan-Dethick
GENERAL COUNSEL AND COMPANY SECRETARY
SIGMA PHARMACEUTICALS LIMITED
ABN 15 088 417 403
Locked Bag 268 (96 Merrindale Drive) Croydon Victoria 3136 Australia
Telephone: (+61-3) 03-9839 2800 Facsimile: (+61-3) 03-9839 2811

Suggested Articles

CureVac named a permanent CEO, Franz-Werner Haas, and signed Novartis alum, Igor Splawski, Ph.D. as its new top scientist.

J&J studied the drug in midphase obesity clinical trials, but Merck sees it as a potential treatment for nonalcoholic steatohepatitis.

The Big Pharma paid $134 million to enter into the two partnerships but then dropped the projects after Voyager completed research activities.